Molecular classification of tissue from a transformed non-Hogkin’s lymphoma case with unexpected long-time remission

Julie Støve Bødker(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Lasse Hjort Jakobsen(Aalborg University Hospital), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Marianne Tang Severinsen(Aalborg University Hospital), Anna A. Schönherz(Aalborg University Hospital), Mette Nyegaard(Statens Serum Institut), Linn Reinholdt(Aalborg University Hospital), Alexander Schmitz(Chr. Hansen (Denmark)), Maria Bach Laursen(Chr. Hansen (Denmark)), Steffen Falgreen(Chr. Hansen (Denmark)), Hanne Due(Aalborg University Hospital), Rasmus Froberg Brøndum(Aarhus University), Martin Bøgsted(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital)
Experimental Hematology and Oncology
January 11, 2017
10.1186/s40164-016-0063-0
Cited by 2

Related Papers

Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
|Blood|2009|390
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362